Japanese encephalitis vaccine (live, attenuated) Completed Phase 4 Trials for Measles / Japanese Encephalitis / Rubella / Mumps Prevention

Indications	Status	Purpose	Phase
DBCOND0013734 (Measles) DBCOND0033178 (Japanese Encephalitis) DBCOND0013737 (Rubella) DBCOND0001978 (Mumps)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02880865	Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine	Japanese encephalitis vaccine (live, attenuated) (DB16577) Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769) Measles virus vaccine live attenuated (DB10315) Mumps virus strain B level jeryl lynn live antigen (DB10316) Rubella virus vaccine (DB10317)